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).a b s t r a c t
Kelch-like 3 (KLHL3) is a component of an E3 ubiquitin ligase complex that regulates blood pressure by
targeting With-No-Lysine (WNK) kinases for degradation. Mutations in KLHL3 cause constitutively
increased renal salt reabsorption and impaired Kþ secretion, resulting in hypertension and hyperkalemia.
Although clinical studies have shown that dietary Kþ intake affects blood pressure, the mechanisms have
been obscure. In this study, we demonstrate that the KLHL3 ubiquitin ligase complex is involved in the
low-Kþ-mediated activation of Na-Cl cotransporter (NCC) in the kidney. In the distal convoluted tubules
of mice eating a low-Kþ diet, we found increased KLHL3 phosphorylation at S433 (KLHL3S433-P), a
modiﬁcation that impairs WNK binding, and also reduced total KLHL3 levels. These changes are
accompanied by the accumulation of the target substrate WNK4, and activation of the downstream ki-
nases SPAK (STE20/SPS1-related proline-alanine-rich protein kinase) and OSR1 (oxidative stress-
responsive 1), resulting in NCC phosphorylation and its accumulation at the plasma membrane.
Increased phosphorylation of S433 was explained by increased levels of active, phosphorylated protein
kinase C (but not protein kinase A), which directly phosphorylates S433. Moreover, in HEK cells
expressing KLHL3 and WNK4, we showed that the activation of protein kinase C by phorbol 12-myristate
13-acetate induces KLHL3S433-P and increases WNK4 levels by abrogating its ubiquitination. These data
demonstrate the role of KLHL3 in low-Kþ-mediated induction of NCC; this physiologic adaptation reduces
distal electrogenic Naþ reabsorption, preventing further renal Kþ loss but promoting increased blood
pressure.
© 2016 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Hypertension affects one billion peopleworldwide, contributing
to death from stroke, cardiovascular disease, and end-stage kidney
disease. Genetic studies of Mendelian forms of hypertension have
demonstrated the key role of Na-Cl handling in the distal nephron
in the long-term control of blood pressure [1,2].
Among the monogenic forms of hypertension,epartment of Internal medi-
aga, Itabashi-ku, Tokyo 173-
p (S. Shibata).
r Inc. This is an open access articlepseudohypoaldosteronism type II (PHAII; also known as familial
hypertensive hyperkalemia, Gordon syndrome, OMIM no. 145260)
is of particular interest because of the unusual phenotype of hy-
pertension and hyperkalemia. Mutations in four genes have been
identiﬁed to cause PHAII [2e4]. Two genes encode serine threonine
kinases With-No-Lysine 1 (WNK1) and WNK4, and the other two
genes encode cullin-3 (CUL3) and Kelch-like 3 (KLHL3), elements of
a RING (really interesting new gene) E3 ubiquitin ligase complex.
Although their roles in blood pressure regulation were not known
at the time of the discovery, subsequent biochemical analysis
revealed their contribution to renal electrolyte homeostasis. WNK's
kinase activity is activated by decreased intracellular Cl levels
[5,6], and directly phosphorylates the kinases SPAK (STE20/SPS1-
related proline-alanine-rich protein kinase) and OSR1 (oxidativeunder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/
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activate the thiazide-sensitive, Na-Cl cotransporter (NCC) in the
distal convoluted tubules (DCT) [8]. Other targets of WNK4 have
also been identiﬁed, including ROMK (renal outer medullary Kþ
channel), which is inhibited independently of the kinase activity
[9]. The KLHL3/CUL3 ubiquitin ligase binds and targets WNK4 and
WNK1 for degradation, regulating their levels [10,11]. In PHAII pa-
tients, missense mutations in the Kelch domain of KLHL3, and in an
acidic domain of WNK4, both abrogate the association of KLHL3
and WNK4, preventing WNK4 degradation and resulting in
constitutive Na-Cl reabsorption with impaired Kþ secretion
[2,4,10,11].
Previously, we have reported phosphorylation at S433 in the
Kelch domain (KLHL3S433-P) that prevents binding and degradation
of WNK4 [12]. Importantly, angiotensin II signaling via protein ki-
nase C (PKC) increases KLHL3S433-P, increasing WNK4 levels in vivo.
In addition, recent data indicate that this site may also be regulated
by vasopressin signaling [13]. These data, together with the fact
that S433 is recurrently mutated in PHAII patients [2,4], show that
the inactivation of KLHL3 either by phosphorylation or single
amino acid substitution is sufﬁcient to have a major impact on
blood pressure levels and on Naþ, Kþ, Cl handling in the kidney.
Clinical studies have demonstrated the inverse relationship
between Kþ intake and blood pressure levels [14,15]. However, the
biochemical pathways that low-Kþ intake increases blood pressure
are not entirely clear. Recent studies reported that NCC activation is
likely to be a central mechanism, given that Kþ depletion and hy-
pokalemia increase NCC phosphorylation independently of plasma
aldosterone [16,17]. The contribution of KLHL3/CUL3-based ubiq-
uitin ligase in this process has been unknown. In this study, we
show that low Kþ suppresses KLHL3 function, which results in NCC
activation by abrogating WNK4 degradation, and activating kinases
SPAK and OSR1.
2. Materials and methods
2.1. Creation of monoclonal antibodies against KLHL3S433-P
Human KLHL3 peptide C-NTRRSS*VGVG (*phospho-Ser), with
cysteine at the N-terminus, was coupled to keyhole limpet hemo-
cyanin, and was injected into mice (Biogate). Spleen cells from the
injected mice were fused with mouse myeloma cells P3U1, and the
hybridomas producing phospho-speciﬁc antibodies were selected
by ELISA and further by dot blot assay [12,18]. The monoclonal
phospho-antibody used in the study displays virtually no cross-
reactivity with unphosphorylated KLHL3 peptide (Supplemental
Fig. 1) nor unphosphorylated KLHL3 protein (see Results section).
2.2. Animals
The present study was approved by the institutional review
board (IRB) in the Teikyo University Review Board #14-018. Male
C57BL/6 mice at 6 weeks of age were obtained from Tokyo Labo-
ratory Animals Science (Japan). Dietary manipulations included a
low (0.005%) or a normal (0.9%) Kþ diet for the indicated period. Na-
Cl content (0.3%) in low-Kþ diet is identical to that in normal-Kþ
diet.
2.3. Western blot
Western blotting was performed as described previously [12,18].
Plasma membrane fraction was puriﬁed using plasma membrane
isolation kit (Invent). Primary antibodies included anti-KLHL3
(Sigma) [12], anti-Flag (Sigma), anti-tubulin (Sigma), anti-WNK4
(produced in the lab; Supplemental Fig. 2), anti-phospho SPAK/OSR1 (Millipore) [19], anti-SPAK (Cell Signaling Technology; CST)
[19], anti-NCC [12], anti-NCC phosphorylated at Thr53 and Thr71
[20], anti-phospho PKC (bearing phosphorylation at Ser660 in
PKCbII; the antibody also detects phosphorylated PKCa, bI, d, ε, h,
and q; CST), anti-phospho PKCa/b (bearing phosphorylation at
Thr638/641; Abcam), anti-total PKC, anti-phospho protein kinase A
(PKA; bearing phosphorylation at Thr197 in the catalytic domain),
and anti-PKA catalytic domain (CST).
2.4. Immunostaining
Immunoﬂuorescence study was performed as described previ-
ously [12,18]. Primary antibodies included polyclonal anti-
KLHL3S433-P [12], anti-aquaporin-2 (Santa Cruz Biotechnology), and
anti-calbindin D28-K (Swant).
2.5. Cell culture, transient transfection and cell treatment
HEK cells were incubated as described previously [21]. Transient
transfection was carried out using non-liposomal polymer (Mirus
Bio) [12]. Where indicated, phorbol 12-myristate 13-acetate (PMA;
200 nM) and bisindolylmaleimide I (BIM; 2 mM) were added.
Ubiquitination assay was performed as described previously [11].
2.6. Statistical analysis
The data are summarized as means ± SEM. Unpaired t-test was
used for comparisons between two groups. For multiple compari-
sons, statistical analysis was performed by ANOVA followed by
Tukey post hoc tests. P value < 0.05 was considered statistically
signiﬁcant.
3. Results
3.1. Low-Kþ diet increases KLHL3S433-P and decreases total KLHL3
levels
We produced a mouse monoclonal antibody that speciﬁcally
recognizes KLHL3S433-P. Western blotting using this antibody with
lysates from cells expressing KLHL3 recognized a signal of appro-
priate size that was absent in cells expressing no KLHL3 or KLHL3
carrying the S433A substitution (Fig. 1A). This signal was also
detected in lysates of mouse kidney, and was abolished by
competition with the immunizing KLHL3 phosphopeptide, but not
unphosphorylated peptide (Fig. 1B). These data establish the
speciﬁcity of the antibody in cells and in vivo, and provide further
evidence that KLHL3S433 is phosphorylated in kidney [12].
To determine whether a change in Kþ status alters KLHL3
function in vivo, we evaluated KLHL3S433-P and total KLHL3 levels by
Western blotting in mice eating a low-Kþ diet. As shown in Fig. 1C
and D, KLHL3 S433-P levels were signiﬁcantly elevated by the low-Kþ
diet at day 7 (P¼ 0.021 versus normal-Kþ group), and also at day 14
(P < 0.001 versus normal-Kþ group). To our interest, total KLHL3
levels were also signiﬁcantly decreased by low Kþ at day 14
(P ¼ 0.001 versus normal-Kþ group; Fig. 1C and D). Given that
KLHL3S433-P impairs the substrate binding ability [12], these data
indicate that the activity of KLHL3/CUL3-based ubiquitin ligase is
markedly suppressed by the net effects of KLHL3S433-P induction
and the decrease in total levels.
In the kidney, KLHL3 is present in distal convoluted tubule (DCT)
cells, cortical thick ascending limb of Henle, and cortical collecting
duct [22]. To determine the nephron segments and cell types in
which low-Kþ diet increases KLHL3S433-P, we performed immuno-
ﬂuorescencemicroscopy using a polyclonal antibody to KLHL3S433-P
[12]. The results showed that KLHL3S433-P levels were increased in
Fig. 1. Kþ depletion increases KLHL3 phosphorylation at S433 and decreases total KLHL3 levels. (A) Western blot analysis of HEK cells expressing no KLHL3, Flag-tagged KLHL3WT or
KLHL3S433A incubated with monoclonal anti-KLHL3S433-P antibody (upper panel) and anti-Flag antibody (lower panel). The signal detected by the anti-KLHL3S433-P is abolished by
the S433A substitution. (B) Total kidney lysates were prepared from mice eating a normal diet. Western blots of the lysates were incubated with anti-KLHL3S433-P antibody without
or with competition with immunizing KLHL3 phosphopeptide and non-phosphopeptide. Competition with the KLHL3 phosphopeptide but not the non-phosphopeptide eliminates
the antibody signal (arrow), conﬁrming the speciﬁcity. (C) KLHL3S433-P and total KLHL3 levels in the kidneys of wild-type mice fed a normal Kþ diet (NK) or a low-Kþ diet (LK)
determined by Western blot analysis in biological replicates. (D) Quantitation of total KLHL3 and KLHL3S433-P levels in the kidney described in (C) (n ¼ 6 or 7 for day 7 and n ¼ 5 for
day 14). Data are expressed as means ± SEM. (E) Kidney sections stained for a-KLHL3S433-P (green, indicated by arrows) and a-calbindin D28-K (a marker for distal convoluted tubule
cells, red) in mice eating a normal-Kþ or a low-Kþ diet. KLHL3S433-P is increased at the apical membrane of distal convoluted cells (which express NCC). Scale bars represent 50 mm.
Glo, glomeruli.
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Fig. 1E) [23], but were negative for aquaporin-2 (a marker for
principal cells; data not shown), demonstrating that KLHL3S433-P is
mainly increased in the DCT cells. In contrast, the increase in
KLHL3S433-P was not evident in the principal cells (Supplemental
Fig. 3).3.2. Increased KLHL3S433-P and decreased total KLHL3 result in
increased WNK4 levels, stimulating SPAK/OSR1-NCC pathway in Kþ
depletion
Previous studies have shown that WNK4 levels are high in DCT
cells [3]. If the activity of KLHL3-based ubiquitin ligase is sup-
pressed by low-Kþ diet, this should result in accumulation of the
target substrate WNK4. We thus examined WNK4 levels in kidneys
of mice eating a low-Kþ diet. As shown in Fig. 2A and B, low-Kþ diet
signiﬁcantly increased WNK4 levels in the kidney (P ¼ 0.018).
When activated, WNK4 phosphorylates the kinases SPAK and
OSR1, the positive regulators of NCC [7,8]. In PHAII patients, mu-
tations in either KLHL3 or WNK4 result in the increased WNK4
levels, promoting hypertension and hyperkalemia that are
correctable by thiazide. Consistently, we found that WNK4 accu-
mulation in the kidney of mice on a low-Kþ diet resulted in the
increased phosphorylation of SPAK/OSR1 (Fig. 2A and C), and NCC
phosphorylation at both Thr53 and Ser71 (Fig. 2D). Moreover,
plasma membrane NCC levels were signiﬁcantly increased in mice
on a low-Kþ diet (Fig. 2E). These data are consistent with a recentreport showing the importance of SPAK in stimulating NCC in hy-
pokalemia [24], and demonstrate that KLHL3 inactivation is the
upstream signal for SPAK/OSR1 activation in Kþ depletion.3.3. Kþ depletion increases PKC activity in vivo in kidney
We next evaluated the mechanism that increases KLHL3S433-P in
the Kþ-depleted condition. We have previously shown that PKC
directly phosphorylates KLHL3S433 in in vitro kinase assays. There is
also a report showing the role of Kþ in regulating PKC [25]. We thus
determined PKC activity in the kidney of mice on a low-Kþ diet. Of
note, Western blotting analysis using antibody against the active,
phosphorylated PKC (pan) revealed that PKC activity was signiﬁ-
cantly increased by Kþ depletion in the kidney (1.8-fold increase;
P < 0.001; Fig. 3A). Given the evidence that KLHL3S433 is also
phosphorylated by PKA [13], we additionally evaluated the levels of
active, phosphorylated PKA (bearing phosphorylation at Thr197 in
the catalytic domain). In mice eating a low-Kþ diet, the levels of
phosphorylated PKA were not signiﬁcantly altered (Fig. 3B).
Among the different PKC isozymes, KLHL3S433 is predominantly
phosphorylated by conventional PKCa and PKCb, and to a lesser
extent by PKCε [12]. Recent studies demonstrated the role of PKCa
in regulating electrolyte handling in the distal nephron [26]. We
next performed Western blotting using phospho-speciﬁc antibody
that recognizes active PKCa/b (bearing phosphorylation at Thr638/
641). Consistently, active, phosphorylated PKCa/b is signiﬁcantly
increased in the kidney by low-Kþ diet (P ¼ 0.003; Fig. 3A).
Fig. 2. KLHL3S433 phosphorylation results in increased WNK4 levels, stimulating SPAK/NCC pathway in the kidney of mice on a low-Kþ diet. (A) Effects of low Kþ diet on WNK4
levels and SPAK/OSR1 phosphorylation in the kidney. Blots show biological replicates. (B and C) Quantitation of WNK4 levels and SPAK/OSR1 phosphorylation levels described in
(A). Data are expressed as means ± SEM; n ¼ 7 for (B) and n ¼ 5 for (C). (D) Effects of low-Kþ diet on NCC phosphorylation at Thr53 and Ser71, and total NCC levels in whole cell
lysates in the kidney. Blots show biological replicates. Bar graphs show the results of quantitation (n ¼ 5 each group). (E) Expression of NCC in the plasma membrane fraction in the
indicated animals (n ¼ 3). Bar graphs show the results of quantitation. Data are expressed as means ± SEM.
Fig. 3. Low-Kþ diet increases protein kinase C activity in the kidney. (A) The effects of Kþ depletion on protein kinase C (PKC) phosphorylation in the kidney. The top panel shows
active, phosphorylated PKC (pan) levels. The middle panel shows the levels of active, phosphorylated PKCa/b. The bottom panel shows the total PKC levels. Blots show biological
replicates. Bar graphs show the results of densitometric quantitation. Data are expressed as means ± SEM; n ¼ 5 each group. (B) The effects of Kþ depletion on protein kinase A
(PKA) phosphorylation in the kidney. Blots show biological replicates. Bar graphs show the results of densitometric quantitation. Data are expressed as means ± SEM; n ¼ 5 each
group.
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prevent KLHL3-mediated ubiquitination and degradation of WNK4
Finally, to show that the activation of endogenous PKC increases
KLHL3S433-P, and that this event is sufﬁcient to prevent the degra-
dation of WNK4, we performed cell culture experiments. HEK cells
expressing KLHL3 were stimulated with PMA, the PKC activator.Cells were then lysed, and the levels of KLHL3S433-P and total KLHL3
were quantitated. As expected, PMA increased the phosphorylated,
active form PKC at 30 min (Fig. 4A). Importantly, PMA signiﬁcantly
increased KLHL3S433-P levels (Fig. 4B; 1.9-fold increase, P < 0.001).
If this effect of PMA is of functional signiﬁcance, KLHL3-
mediated WNK4 degradation [11] should be prevented by the in-
cubation of PMA. To test this, cells co-expressing KLHL3 and WNK4
Fig. 4. PKC activator PMA increases KLHL3 S433-P, preventing ubiquitination and degradation of WNK4 in HEK cells. (A) Plasmid encoding wild-type Flag-KLHL3 was transfected in
HEK cells. An empty vector was used as control to equalize the total amount of DNA in transfection lacking KLHL3. Cells were incubated in the presence or absence of the PKC
activator phorbol 12-myristate 13-acetate (PMA, 200 nM) for 30 min. Levels of phosphorylated PKC (pPKC) and total PKC were quantitated by Western blotting. Bar graphs show the
results of quantitation. (B) Cell lysates described in (A) were subjected to Western blotting with monoclonal a-KLHL3S433-P, a-Flag (to detect total KLHL3), and a-tubulin. Bar graphs
show the results of quantitation. Data are expressed as means ± SEM; n ¼ 5 each group. (C) HEK cells expressing Flag-KLHL3 and WNK4-HA were incubated in the presence and
absence of PMA (200 nM) for 24 h. To conﬁrm that the effect of PMA is mediated by PKC, one group was incubated with bisindolylmaleimide I (BIM), the PKC inhibitor. Bar graphs
show the results of quantitation. Data are expressed as means ± SEM; n ¼ 6 each group. (D) HEK cells expressing the indicated proteins were incubated in the presence or absence of
PMA for 1 h. Ubiquitinated WNK4 levels were analyzed by in vivo ubiquitination assay. The asterisk indicates the ubiquitinated WNK4. KLHL3-mediated WNK4 ubiquitination is
abrogated by PMA treatment. Total WNK4 levels were consistently higher in cells incubated with PMA.
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prevented the KLHL3-mediated reduction in WNK4 levels in cells
co-expressing KLHL3 and WNK4 (Fig. 4C; KLHL3 versus
KLHL3 þPMA, P < 0.0001; control versus KLHL3 þ PMA, P ¼ not
signiﬁcant). In addition, these effects of PMA were fully prevented
by bisindolylmaleimide I, the selective inhibitor of PKC (Fig. 4C).
Lastly, binding of WNK4 by KLHL3 leads to its poly-
ubiquitination, leading to WNK4 degradation [11]. We tested
whether PKC activation by PMA is capable of abrogating this effect.
HEK cells expressing KLHL3 and WNK4 were incubated in the
absence or presence of PMA. Cell lysates were then subjected to an
in vivo ubiquitination assay [11]. The results demonstrated that
WNK4 ubiquitination by KLHL3 was prevented by PMA (Fig. 4D).
These data demonstrate that the induction of KLHL3S433-P by PKC is
sufﬁcient to increase WNK4 levels by preventing KLHL3-mediated
ubiquitination and degradation of WNK4.
4. Discussion
We here demonstrated that suppression of KLHL3/CUL3-based
ubiquitin ligase mediates NCC activation by low-Kþ diet. In the
kidney, low-Kþ diet results in increased PKCa/b activity and
KLHL3S433-P levels in the DCT, leading to increased WNK4 levels.This, in turn, results in the activation of the kinases SPAK/OSR1,
increasing NCC phosphorylation and activity. Indeed, we showed in
cell culture that PKC activation is sufﬁcient to increaseWNK4 levels
by phosphorylating KLHL3S433 and preventing WNK4 ubiquitina-
tion. Besides KLHL3S433-P induction, we also found that low-Kþ diet
results in reduced total KLHL3 levels. These data for the ﬁrst time
demonstrate the involvement of KLHL3/CUL3-based ubiquitin
ligase in low-Kþ-mediated NCC induction.
It is well described and accepted that the reduced Kþ intake is
associated with hypertension [14,15]. Accumulating evidence in-
dicates a key role of NCC in this process [16], and it is recently
postulated that hypokalemia alters the resting membrane potential
in DCT cells, which in turn changes intracellular Cl levels,
increasing the kinase activity of the Cl-regulated kinase WNK4
[5,17]. Our ﬁndings provide an alternative or additional mechanism
for this effect. The increase in WNK4 levels by KLHL3 inactivation
and WNK4 kinase activation by the change in intracellular Cl
levels synergistically activate SPAK/OSR1-NCC pathway and Na-Cl
transport in DCT cells. Given that WNK1 is a potent activator of
NCC [27], and that KLHL3 binds and targets WNK1 for degradation
[10,11,22], it is likely that WNK1 is also involved in this mechanism.
Kinase-inactive WNK4 inhibits WNK1 [27]. We infer that WNK1 is
similarly increased by the inactivation of KLHL3, which then
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cellular Cl levels, increasing NCC activity [27]. A very recent study
also suggests a Cl and SPAK/OSR1-independent component [28],
adding an additional layer of NCC regulation by extracellular Kþ.
These mechanisms act in concert to reduce distal electrogenic Naþ
reabsorption by increasing NCC, preventing further renal Kþ loss
but promoting hypertension.
The physiological impact of the proposed pathway is under-
scored by the effects of point mutations in KLHL3 that alter S433
[2,4]. In PHAII patients, either KLHL3S433N or KLHL3S433G substitu-
tion is sufﬁcient to cause hypertension and hyperkalemia that are
correctable by thiazide [2,4]. The fact that angiotensin II signaling
[12] and Kþ depletion share a common mechanism via their effect
on PKC also supports the critical importance of phosphorylation
status at this site in regulating NCC activity. The increase in NCC
activity in hypokalemia acts to minimize Kþ excretion acutely by
reducing Naþ delivery to the collecting duct, thereby reducing
electrogenic Naþ reabsorption and blunting the electrical driving
force for Kþ secretion. Thus, this physiological mechanism to reduce
renal Kþ secretion in the setting of Kþ depletion occurs at the
expense of increased renal Na-Cl reabsorption.
Another important observation in this study is that total KLHL3
levels are decreased by low-Kþ diet. Previous data by Ohta et al.
have reported that CUL3 is capable of ubiquitinating KLHL3 [10].
There are also data showing that the PHAII-causing mutant CUL3
(CUL3 D403-459) displayed increased ubiquitination of KLHL3
[22,29]. Given these data, it is possible that low-Kþ diet alters the
function of CUL3, promoting KLHL3 ubiquitination. Alternatively,
phosphorylation of KLHL3 not only impairs its substrate binding,
but may also alter its stability. Additionally, the mechanisms
whereby low-Kþ diet increases PKC activity are currently unknown.
Whether hypokalemia, as-yet-unidentiﬁed gut-kidney signaling
[30], or both, play causative roles are areas for future investigation.
Given the evidence that WNK4 ampliﬁes the action of PKC [31], it
may also be possible that WNK4 activation by intracellular Cl
depletion is involved in KLHL3S433-P induction.
In summary, our data demonstrate that the KLHL3/CUL3-based
ubiquitin ligase is involved in the low-Kþ-mediated activation of
NCC. Our data reveal a previously unrecognized pathway in which
reduced Kþ intake alters Na-Cl reabsorption in the kidney, and
underscore the physiological importance of ubiquitin proteasome
system in controlling ﬂuid and electrolyte homeostasis. These data
also highlight the importance of the appropriatemanagement of Kþ
intake in hypertensive patients.
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